Alvotech (NASDAQ:ALVOW) Trading Down 19.9% – Here’s Why
by Tristan Rich · The Markets DailyShares of Alvotech (NASDAQ:ALVOW – Get Free Report) fell 19.9% during trading on Wednesday . The company traded as low as $0.2003 and last traded at $0.2003. Approximately 1,650 shares were traded during mid-day trading, a decline of 66% from the average daily volume of 4,838 shares. The stock had previously closed at $0.25.
Alvotech Price Performance
The stock’s 50 day simple moving average is $0.25 and its two-hundred day simple moving average is $0.39.
About Alvotech
Alvotech is a biopharmaceutical company specializing in the development and manufacturing of biosimilar medicines. Headquartered in Reykjavík, Iceland, the company focuses on creating high-quality, cost-effective alternatives to branded biologic therapies. Since its founding in 2013, Alvotech has built an integrated platform that spans research and development, clinical trials, regulatory submissions and commercial manufacturing.
Alvotech’s pipeline includes multiple biosimilar candidates addressing key therapeutic areas such as immunology, oncology and ophthalmology.